Biotech: Lonza Ties with Cellectis to Improve Cell Lines
19:22 PM | June 8, 2010 | Alex Scott
Lonza says it has agreed a deal with Cellectis (Paris; France), a biotech firm involved in genome customization, to develop and commercialize bioengineered cell lines for manufacturing biologic drugs...
This information is only available to subscribers.
chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.